Use of Antimalarial in the Management of Fever during a Community Survey in the Kintampo Districts of Ghana. by Abokyi, Livesy Naafoe et al.
Abokyi, Livesy Naafoe; Asante, Kwaku Poku; Mahama, Emmanuel;
Gyaase, Stephaney; Sulemana, Abubakari; Kwarteng, Anthony; Ayaam,
Jennifer; Dosoo, David; Adu-Gyasi, Dennis; Etego, Seeba Amenga;
Ogutu, Bernhards; Akweongo, Patricia; Owusu-Agyei, Seth (2015)
Use of Antimalarial in the Management of Fever during a Commu-
nity Survey in the Kintampo Districts of Ghana. PLOS ONE, 10 (11).
ISSN 1932-6203 DOI: https://doi.org/10.1371/journal.pone.0142106
Downloaded from: http://researchonline.lshtm.ac.uk/4651934/
DOI: 10.1371/journal.pone.0142106
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH ARTICLE
Use of Antimalarial in the Management of
Fever during a Community Survey in the
Kintampo Districts of Ghana
Livesy Naafoe Abokyi1*, Kwaku Poku Asante1, Emmanuel Mahama1, Stephaney Gyaase1,
Abubakari Sulemana1, Anthony Kwarteng1, Jennifer Ayaam1, David Dosoo1, Dennis Adu-
Gyasi1, Seeba Amenga Etego1, Bernhards Ogutu2, Patricia Akweongo3, Seth Owusu-
Agyei1
1 Kintampo Health Research Centre, P. O. Box 200, Kintampo, Brong Ahafo Region, 2 INDEPTH Network,
East Legon, P.O. Box KD 213 Kanda, Accra, Ghana, 3 School of Public Health, College of Health Sciences,
PO Box LG-13, Legon, Accra, Ghana
* livesy.abokyi@kintampo-hrc.org
Abstract
Background
Epidemiology of malaria and related fevers in most parts of Africa is changing due to scale
up of interventions such as appropriate use of ACTs in the effort towards sustained control
and eventual elimination of malaria. The use of ACTs in the management of malaria-associ-
ated fever was evaluated in the Kintampo districts of Ghana.
Methods
Household survey was conducted between October 2009 and February, 2011. A random
selection of 370 households was generated from 25,000 households existing within the
Health and Demographic Surveillance Systems in Kintampo, Ghana at the time. All house-
hold members present at the time of survey in the eligible households were interviewed
based on a two weeks reported fever recall and the use of antimalarial for the management
of fever. A finger-prick blood sample was also obtained from each member of the household
present and later examined for malaria parasites using microscopy. Descriptive analysis
was performed, with univariate and multivariate analysis used to identify predictors of fever
and malaria parasitemia.
Results
A total of 1436 individuals were interviewed from 370 households. Overall, fever prevalence
was 23.8% (341/1436) and was 38.8% (77/198) in children < 5 years, 21.3% (264/1238) in
older children plus adults. Participants who sought treatment for fever were 84% (285/341)
with 47.7% (136/285) using any anti-malarial. Artemisinin-based Combination Therapy use
was in 69.1% (94/136) of cases while 30.9% used mono-therapies. Malaria parasitaemia
rate was 28.2% (397/1407).
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Conclusion
The study reports high community fever prevalence, frequent use of antimalarials for fever
treatment and relatively high use of mono-therapies especially in children < 5 years in an
area with high malaria parasite prevalence in Ghana.
Introduction
The decline in malaria transmission, malaria related fevers and consequently mortality due to
malaria has been reported in most parts of sub-Saharan Africa [1–8]. This is as a result of avail-
ability of more effective malaria control tools, including those used for malaria case manage-
ment [9–13].
Considerable reduction of fevers associated with Plasmodium falciparum from a median of
44% to 22% has been reported over two decades in sub-Saharan Africa [14]. Declining parasite
prevalence and malaria mortality have also been reported in Tanzania, Rwanda, Ethiopia Zan-
zibar and Kenya [3–5, 15]. Although the signs and symptoms of malaria are non-specific, fever
is a major symptom for malaria and until recently, fever formed the clinical basis for presump-
tive treatment of malaria in high malaria transmission areas [16–20].
In line with WHO recommendation for use of ACTs in managing Plasmodium falciparum
uncomplicated malaria, Ghana changed her anti-malarial drug policy from the use of mono-
therapies such as chloroquine or sulphadoxine-pyrimethemine (SP) to the current artesunate-
amodiaquine (AS-AQ) in 2004 and later included artemether-lumefantrine (AR-LU) and dihy-
droartemisinin piperaquine (DHP) as alternate first-line treatment [21]. Malaria is a common
cause of fever in Ghana as in other malaria endemic countries. Fever in the presence of malaria
parasites at the population-level are important indicators for levels of malaria transmission and
malaria risks in the communities surveyed. The prevalence of population-level fever and
malaria infection have direct impact on malaria case management and use antimalarials. More-
over it was important to assess the use of ACTs in rural populations after five years of the intro-
duction of ACTs.
This study therefore evaluates the use of ACTs for fever as well as fever and malaria parasite
prevalence in the Kintampo districts of Ghana. This study was part of a phase IV study of arte-
misinin combination therapies (ACT) referred to as INDEPTH Effectiveness and Safety Study
(INESS) and carried out by the Kintampo Health Research Centre as part of a consortium that
evaluated the effectiveness and safety of antimalarials in sub-Saharan Africa.
Methods
Study area
The study was carried out in the Kintampo North and South Districts, which are located within
the forest-savanna, transitional zone in the Brong Ahafo Region of Ghana. These two districts
cover an area of about 7,162 square kms with a residential population of approximately
134,970 within 29,073 households and a median household size of five as at 2009 [22]. The
main rainy season is from May to October with an average rainfall of 1250 mm per annum and
mean monthly temperature range of 18–38°C. Entomological inoculation rate (EIR) of 231–
269 infective bites per person per year [23]. Malaria transmission is perennial with a high
annual prevalence of 58% [24]. The study area has two district hospitals, twelve public and pri-
vate health centres and clinics and thirty community health planning and services (CHPS)
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compounds. There are also about sixty chemical shops spread within the two districts. Antima-
larials are sold over the counter in the two districts as in most parts of Ghana.
Study design
The study comprised of household surveys conducted between October 2009 and February
2011. The outcome variables of interest were reported fever and treatment sought two weeks
preceding interview, the presence of malaria parasitaemia confirmed by malaria microscopy
and the use of ACTs in the management of fevers. The interview was performed by study team
comprising field workers and investigators using predesigned and tested questionnaires.
Demographic (gender and age) and independent variables (level of education, wealth index,
residence type) were used to determine predictors of fever and malaria parasitaemia in the
studied population.
Study population and sampling methods
The study was conducted among households randomly selected from the Kintampo Health
and Demographic Surveillance System (KHDSS) database, using the resident population as
sampling frame. The KHDSS, which is conducted by the Kintampo Health Research Centre
(KHRC), covers the entire Kintampo North Municipality (KNM) and the Kintampo South
District (KSD). Routine updates of basic health and demographic events of the resident popula-
tion are core to the KHDSS activities. During the period of this survey, each household was vis-
ited three times in a year (once in every four months) to update their basic health and
demographic data.
Three hundred and seventy (370) households were randomly selected from a total 25,000
households within the KHDSS. A total of 1436 members interviewed with all resident house-
hold members from selected households being interviewed. The sample size was calculated
based on a hypothesized average fever prevalence rate of 26% (0.26) given that prevalence in
the study area is expected to be higher than the national prevalence of 20% in 2008 ([25]). The
expected prevalence of fever in the study area was postulated as 30% (0.30). Using these, a sam-
ple size of 1309 was arrived at. A non-response rate of 10% was estimated to arrive at a sample
size of 1439. This sample size was calculated for 370 households; however 1436 households
based on 4 members per household were eventually interviewed.
Data collection
Face-to-face interviews were conducted for all household members within each selected house-
hold. All respondents consented; adults 18 years and above gave consent on their own behalf
and caregivers of minors (<18 years) consented on behalf of minors. Additionally assents were
sought from children 12–17years old.
Respondents were asked if they have had fever within two weeks preceding the interview
and whether they sought care for the fever episode they reported. Those who sought care were
also asked if they took any antimalarials for that fever episode. To facilitate identification of
antimalarials used for treatment of this fever episode, a picture catalogue of commonly used
antimalarials in the drug shops and pharmacies in the study area was shown to participants.
Study team members trained in good laboratory practices, assisted in collecting finger-prick
blood samples in Ethylene Diamine Tetra-acetic Acid (EDTA) tubes that were transported to
the Kintampo Health Research Centre Clinical laboratory for slide and identification of malaria
parasites by microscopy.
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Malaria microscopy
Thin films were fixed with methanol. Both thin and thick films were stained with Giemsa and
examined for the presence of malaria parasites using a 100x oil immersion lens. Each smear
was independently read by two expert microscopists at KHRC to determine the presence and
quantification of malaria parasites. A third microscopist was required to read the smear only if
there was discordance between the first two readers on any of the two parameters as described
by Swysen and others [26].
Data management and statistical analysis
All completed forms were checked for consistency and completeness, logged into the computer
laboratory of the Kintampo Health Research Centre before double data entry and processing
using Visual FoxPro 6.0. Data analysis was done using Stata Corp 11, TX USA. Descriptive sta-
tistics were used to generate relative frequencies for demographic data and outcome of interest
(fever and parasite prevalence) as well as types of antimalarials used in managing fevers. Both
univariate and multivariate logistic regressions were carried out to determine demographic
(gender and age) and socio-economic (educational level and wealth index) as predictors of
fever and parasitaemia in the population. Odds ratio with 95% confidence interval were used to
measure the strength of association at statistical level of P<0.05. Clustering was adjusted for
using the robust standard error estimation.
Ethical approval
The study protocol and instruments were reviewed and approved by the Ethics Committees of
Kintampo Health Research Centre with Federal Wide Assurance (FWA) Number 00011103
and Ghana Health Service with Ethical Clearance ID: GH-ERC:06/5/09. The study team held
community meetings with opinion leaders and community members to obtain approval for the
study. Written informed consent was obtained from all adult participants, care-givers provided
consent for their children and adolescents was also obtained.
Results
Demographic characteristics of participants, fever and malaria parasite prevalence survey:
Three hundred and seventy households 370 households participated in the study and had
household members interviewed and blood sample collected for malaria microscopy. Fever
was reported in 20.8% (77) of the households and with malaria parasites being detected in
11.6% (43) of households. In total 1436 individuals from the households participated in the
study. About 53.7% (771) were females and 13.8% (198/1436) children< 5 years (Table 1). Of
the 1436 participants interviewed, 23.8% (342) reported fever within the preceding two weeks
period (Table 1). The prevalence of history of fever among children< 5 years of age and the
rest of study population was 38.8% (77/198) and 21.3% (264/1238) respectively. Fever preva-
lence was relatively higher among males (25.7%) than among females (22.2%).
Overall prevalence of malaria parasitaemia in this population was 28.2% (397/1436)
(Table 1) with a prevalence of 37.1% (72/194) in children< 5 years and 26.8% (325/1213) in
the rest of the study population. Parasitaemia was detected in 24.9% (85/341) of those who
reported fever in the preceding two weeks. Plasmodium falciparum infection accounted for
91.4% (363/397) of infections and P.malaraie accounted for 3.3% (13/397). Mixed infections
of P. falciparum and P.malaraie accounted for 5.3% (21//397) of individuals with malaria
parasitaemia.
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Treatment seeking and type of antimalarials used
Majority of the participants who reported fever, 83.6% (285/341) sought treatment (Table 2).
However treatment seeking for fever was higher 93.5% (72/77) among children< 5 years of
age compared to older children and adults 80.7% (213/264) (Table 2). Among all who sought
treatment, 47.7% (136/285) took antimalarials. About 59.7% (43/72) of children<5 years and
43.7% (93/213) of older children and adults took antimalarials (Table 2). Those who used
ACTs (artesunate-amodiaquine and artemther-lumifantrine) were 69.1% (94/136) while 30.9%
(42/136) used mono-therapies (Table 2). More children< 5 years of age 48.8% (21/43) were
given mono-therapies compared with older children and adults, 22.6% (21/93). Mono-thera-
pies used were mainly amodiaquine, artemether, artesunate, chloroquine and sulphadoxine-
pyrimethamine.
Table 2. Use of antimalarials among participants who sought treatment for fever.
Treatment sought Total n (%) < 5 yrs n(%)  5 yrs n(%)
Sought treatment 285 (83.6) 72 (93.5) 213 (80.7)
Used antimalarial 136 (47.7) 43 (59.7) 93 (43.7)
Used recommended ACT 94 (27.6) 22(28.6) 72 (27.3)
Used mono-therapies 42 (12.3) 21 (27.3) 21 (8.0)
Use of ACT among participants who used antimalarial 94 (69.1) 22 (51.2) 72 (77.4)
Artesunate-Amodiaquine 75 (79.8) 18 (81.8) 57 (79.2)
Artemether-Lumefantrine 19 (20.2) 4 (18.2) 15 (20.8)
Amodiaquine 21 (50.0) 16 (76.2) 5 (23.8)
Sulphadoxine-pyrimethamine 16 (38.1) 2 (9.5) 14 (66.7)
Other monotherapies 4 (9.6) 3 (14.3) 1 (4.8)
doi:10.1371/journal.pone.0142106.t002
Table 1. Demographic characteristics of 1436 participants, reported fever and parasitaemia infection
at household and individual levels.
Demographic Characteristics No. of persons interviewed n(%)
Households interviewed 370(100)
Households with fever 77(20.8)
Households with parasitaemia 43(11.6)
Sex
Male 665(46.3)
Female 771(53.7)
Age group
< 5yrs 198(13.8)
 5yrs 238(86.2)
Individuals interviewed 1436(100)
Individuals who reported fever 341(23.8)
Individuals who had malaria parasites 397(28.2)
Parasitaemia among those reporting fever 85(24.9)
*Proportion of plasmodia that were P.falciparum infection 363(91.4)
Rural residents 888(61.8)
Urban residents 548(38.2)
*29 blood slides were missing
doi:10.1371/journal.pone.0142106.t001
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Less than half of the participants who sought treatment 475 (136/285) took antimalarials.
However a higher proportion; 59.7% (43/72) of children< 5 years took an antimalarial com-
pared with 43% (93/213) for older children and adults (Table 2). Among participants who took
antimalarial, 69.1% (94/136) used the nationally recommended firstline ACTs which are arte-
sunate-amodiaquine and artemether-lumefantrine. The remaining 30.9% (42/136) used mono-
therapies which were mainly amodiaquine and sulphadoxine-pyrimethamine. A higher
proportion of children< 5 years, 48% (21/43) used monotherapies compared with 22.6% (21/
93) of older children and adults. Among those who took antimalarial, a higher proportion of
older children and adults (77.4%) took ACTS compared with children< 5 years; 51.2% (22/43)
(Table 2).
Univariate and multivariate predictors of fever and parasitaemia
Both univariate and multivariate logistic regression were used to determine associations
between fever, demographic and socio-economic predictors of participants. Only age was sig-
nificantly associated with the occurrence of fever. Children< 5 years old demonstrated
increased risk of fever in both the univariate (OR = 2.35, 95% CI, 1.71–3.22, P<0.001) and mul-
tivariate (OR = 2.32, 95% CI, 1.69–3.19, P<0.001) analysis. All the other predictors: gender,
educational level of household head, wealth index and place of residence were not significantly
associated with the occurrence of fever (Table 3).
All the predictors, except gender, were significantly associated with the occurrence of parasi-
taemia. For age, children< 5 years old demonstrated association with occurrence of malaria
parasitaemia by both univariate (OR = 1.61, 95% CI, 1.17–2.22, P = 0.003) and multivariate
(OR = 1.63, 95% CI, 1.10–2.24, P = 0.02) analysis (Table 4). Level of education of household
heads was significantly associated with presence of parasitaemia when univariate analysis was
carried out. Participants whose household heads had primary education were more likely to
have malaria infection (49.0%, OR = 2.48, 95% CI, 1.40–4.41) compared with those with no
education (Table 4).
Wealth index was significantly associated with occurrence of malaria infection. When uni-
variate analysis was carried out, participants from both poor households (30.7%, OR = 0.66,
95% CI, 0.49, 0.91, P<0.003) and least poor households (14.1%, OR = 0.25, 95% CI, 0.17, 0.36,
P<0.001were less likely to have malaria infection compared with those from very poor (39.9%)
households. Also in the multivariate analysis, belonging to a very poor household significantly
associated one with malaria infection (P<0.001). The poor households (OR = 0.72, 95% CI,
0.52–0.99) and least poor households (OR = 0.32, 95% CI, 0.20–0.50) were less likely associated
with malaria infection (Table 4).
Fewer urban residents (18.1%) had malaria parasites compared with their rural residents
(34.4%) and residing in rural areas was significantly associated with occurrence of malaria
parasitemia: univariate (OR = 0.42, 95% CI, 0.32–0.55, P<0.001) and multivariate (OR = 0.58,
95% CI, 0.38–0.89, P = 0.013).
Discussion
The community fever prevalence was 23.8%. Children< 5 years of age had a higher fever prev-
alence (38.8%); and this was higher than the national prevalence of 19% in a similar age group
from the multiple indicator cluster survey [27]. Studies from other parts of Ghana, Nigeria,
Kenya and Sierra Leone among others across Africa have also reported lower fever prevalence
ranging from 16% to 26% [28, 29] in children< 5 years of age. The higher fever prevalence
observed among children in this study could be as a result of the higher burden of malaria in
the study area ([24]). High incidence of fever may also result from non-adherence to
Antimalarial Use in Community Fever Management in Ghana
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Table 3. Univariate andmultivariate logistic logistic regression for predictors of fever among 341 residents of the Kintampo North Municipality
and Kintampo South District.
Unadjusted odds ratio (univariate) Adjusted odds (multivariate)
Characteristics N (%) Odds ratio 95% CI P-value Odds ratio 95% CI P-value
Gender
Male 170 (25.6) 1 1
Female 171 (22.2) 0.83 0.65, 1.06 0.13 0.86 0.67, 1.10 0.22
Age group
 5yrs 264 (21.3) 1 1
< 5yrs 77 (38.9) 2.35 1.71, 3.22 <0.001 2.32 1.69, 3.19 <0.001
Educational level of HH
None 140 (21.8) 1
Primary 9 (17.7) 0.77 0.36, 1.61
Middle/JSS 49 (20.3) 0.91 0.63, 1.31 0.732
Technical/SSS and above 16 (25.4) 1.22 0.63, 2.36
Wealth index
Very poor 81 (23.0) 1
Poor 65 (18.6) 0.77 0.53, 1.11 0.283
Least poor 79 (22.8) 0.99 0.70, 1.41
Residence
Rural 199 (22.4) 1 0.13
Urban 142 (25.9) 1.21 0.95, 1.55
doi:10.1371/journal.pone.0142106.t003
Table 4. Univariate andmultivariate logistic logistic regression for predictors of malaria infection among residents of the Kintampo North Munici-
pality and Kintampo South District.
Unadjusted odds ratio (univariate) Adjusted odds (multivariate)
Characteristics N (%) Odds ratio 95% CI P-value Odds ratio 95% CI P-value
Gender
Male 194 (29.9) 1
Female 203 (26.8) 0.87 0.68, 1.09 0.21
Age group
 5yrs 325 (26.8) 1 1
< 5yrs 72 (37.1) 1.61 1.17, 2.22 0.003 1.63 1.10, 2.42 0.02
Educational level of HH
None 179 (28.5) 1
Primary 25 (50.0) 2.48 1.40, 4.41
Middle/JSS 58 (24.9) 0.81 0.58, 1.15 0.003
Technical/SSS and above 13 (20.6) 0.67 0.36, 1.27
Wealth index
Very poor 141 (39.9) 1 1
Poor 107 (30.7) 0.66 0.49, 0.91 <0.001 1.72 O.52, 0.99 <0.001
Least poor 49 (14.1) 0.25 0.17, 0.36 0.32 0.20, 0.50
Residence
Rural 301 (34.4) 1 1
Urban 96 (18.1) 0.42 0.32, 0.55 <0.001 0.58 0.38, 0.89 0.013
doi:10.1371/journal.pone.0142106.t004
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antimalarial treatment leading to poor treatment outcomes and recurrent fever episodes or the
use of ineffective ACTs for malaria episodes. Although adherence to treatment and recrudes-
cence were not investigated in this study, studies carried out in the study area have reported
high adherence to ACTs and low recrudescence ([30, 31]). The fever prevalence in children
was higher among the rural population compared to their urban counterparts and this can be
due to increased risk to infectious pathogens in rural areas.
In this study, age group was the only significant predictor of fever with children< 5 years
accounting for most of the fever events compared with older children and adults. Wealth
index, educational level and place of residence were not strongly associated with fever events.
This finding is contrary to findings from other studies [28, 29, 32] where poverty, low level of
education and rural residence significantly influenced the occurrence of fever. The weak associ-
ation between wealth index, level of education and place of residence with fever could be due to
the small numbers involved in the analysis and so this occurrence could be due to chance.
The malaria parasite prevalence in the general population was 28.2%, with prevalence in
children< 5 years being 37.1%. This percentage is higher than the national prevalence of 28%
reported among children< 5 years [27] but much lower compared with the 58% prevalence
reported in 2004 from the same study area seven years prior to this survey [24]. This suggests a
decline in malaria parasite prevalence in the study area among this age group but still higher
than the national prevalence of 19% ([27]) which is an estimate from across the whole country
with different levels of malaria transmission ([33, 34]). The reason could be due to the national
scale of the national demographic and health survey which may not have been powered enough
to detect difference in parasiteamia. Our study however is more specific or targeted to a smaller
geographical area and may be more accurate. Although a decline in parasite prevalence and
malaria morbidity has also been reported in numerous studies across Africa [5, 14, 35] due to
scale-up of malaria control interventions, certain areas could still have high transmission. The
prevalence of malaria parasitaemia among children less than five years of age is usually used as
an estimate to determine the burden of malaria in an area [33]. In our study, the prevalence of
malaria parasitaemia infection for this age group was high, an indication that malaria transmis-
sion is still very high in the area.
This study also demonstrated that only one in four of the participants who reported fever
had parasitaemia. This implies that three out of four reported fevers could be related to other
conditions rather than malaria. Similar findings where a minority of fevers may be malaria
have also been reported [36–39]. This justifies the need for confirmed diagnosis of malaria in
health facilities to address over-diagnosis and missed diagnosis and treatment of other causes
of fever. Over-diagnosis and subsequent treatment with effective and expensive ACTs is a
waste and a drain of resources and invariably increases drug pressure and drug resistance.
Parasitological diagnosis of malaria in endemic areas remains important and is recommended
[14, 40, 41]. However confirmed parasitological diagnosis requires that microscopy or RDTs
are available and used properly by health care providers [42] and this is the only way to ensure
rational use of antimalarials.
Age, level of education, wealth index and place of residence were all significantly associated
with occurrence of malaria parasitaemia. Children< 5 years of age were more likely to have
parasitaemia compared to older children and adults and this could be explained by low immu-
nity status of very young children. Urban dwellers were less likely to have parasitaemia compared
to their rural counterparts possibly due to a difference in transmission as well as living in well-
screened houses that prevent/reduce mosquito bites. The association of early childhood, rural
residence and lower wealth index with parasitaemia is consistent with other studies [29, 40].
In this study, 84% of participants who reported of fever and had sought treatment compared
with previously reported rates of 73%–78% among children< 5 years across six sub-Saharan
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African countries [43]. However, a study in Sudan reported only 39% treatment seeking [32].
The implementation of NHIS in Ghana, which aims at improving financial access to health
care could have accounted for prompt care seeking. This must however be interpreted with
some caution since information was not obtained by study team on the type or place of care.
Despite the high use of ACTs, this study also reported that one-third of those who received
antimalarials used monotherapies which is relatively high at a time when all monotherapies are
supposed to have been withdrawn from the market and all health facilities. In a community-
based study in 2006, two years after the implementation of ACTs as first-line treatment for
antimalarial in the same study area, only 12% to 14% of the respondents used the nationally
recommended ACTs for treatment of malaria with 50% still using chloroquine for malaria
treatment. In 2006 and 2009, studies in Ghana showed that only 43.0% and 33.0% of patients
respectively treated at the health facilities received the nationally recommended ACTs [44]
[45].
This study also shows that more children< 5years old received antimalarials compared
with older children and adults, however more of the antimalarials received by children< 5
years were monotherapies. This raises some concerns since children are more vulnerable and
bare the highest burden of malaria related morbidity and mortality. Availability of more non-
tablet peadiatric ACT drug formulations which can be better administered instead of the con-
ventional tablets could improve uptake of ACTs among children ([46]).
The uptake of ACTs could also be influenced by price although this was not investigated in
our study. A reduction in the price of ACTs through the affordable medicines facility for
malaria, increased the uptake of ACTs (AL) from less than 1% to 42% in Tanzania and from
15% to 42% in Kenya ([47].
This study also reported higher uptake of AS-AQ compared to AL. This could be because
AS-AQ was first introduced as firstline treatment for uncomplicated malaria in Ghana in 2004.
The policy was later revised to include AL and dihydoartemisinin pepiraquine (DHP) as alter-
nate treatments in 2009 due to reports of adverse drug reactions reported among the public
([21]).
Conclusion
Although a high proportion of participants in our study used the nationally recommended
malaria treatment, intensified efforts need to be in place to increase the uptake of ACTs for the
management of malaria and crowd out monotherapies.
Fever and malaria parasite prevalence remains high in Kintampo area with high proportion
of fever patients being presumptively treated with antimalarials resulting in malaria overtreat-
ment with one third still using monotherapies. There is the need to enforce the use of ACTs
and the withdrawal of monotherapies as well as continual monitoring of compliance to malaria
treatment guidelines.
Limitations
Other causes of fever were not sought and the effect of clustering of participants in households
could also lead to biases in malaria parasitaemia prevalence.
Acknowledgments
The study team is most grateful to the community members of Kintampo North Municipality
and Kintampo South District particularly the study participants. We also thank the field, com-
puting, laboratory and administrative staff of the Kintampo Health Research Centre for their
support. We acknowledge the pivotal role of INDEPTH Network especially the INESS
Antimalarial Use in Community Fever Management in Ghana
PLOSONE | DOI:10.1371/journal.pone.0142106 November 18, 2015 9 / 12
secretariat in securing funds and coordinating the study. The study was supported by grant
from the Bill and Melinda Gates Foundation to the INDEPTH-Network. Kintampo Health
Research Centre is a member of the INDEPTH Network.
Author Contributions
Conceived and designed the experiments: LNA KPA AK DD DAG AS PA SOA. Performed the
experiments: LNA JA SG AS DD DAG AK. Analyzed the data: LNA KPA EM SG AK AS JA
DD DAG SAE PA SOA. Contributed reagents/materials/analysis tools: LNA KPA EM DD
DAG SAE SOA. Wrote the paper: LNA KPA EM SG AK JA DAG DD BO PA SOA.
References
1. D'Acremont V, Lengeler C, Mshinda H, Mtasiwa D, Tanner M, Genton B. Time to move from presump-
tive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever.
PLoS Med. 2009; 6(1):e252. Epub 2009/01/09. 08-PLME-PMD-2512 [pii] doi: 10.1371/journal.pmed.
0050252 PMID: 19127974; PubMed Central PMCID: PMC2613421.
2. Bosman A, Mendis KN. A major transition in malaria treatment: the adoption and deployment of artemi-
sinin-based combination therapies. Am J Trop Med Hyg. 2007; 77(6 Suppl):193–7. Epub 2008/01/31.
77/6_Suppl/193 [pii]. PMID: 18165492.
3. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, et al. Impact of artemisinin-based
combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007; 4
(11):e309. Epub 2007/11/09. 07-PLME-RA-0164 [pii] doi: 10.1371/journal.pmed.0040309 PMID:
17988171; PubMed Central PMCID: PMC2062481.
4. Otten M, Aregawi M, WereW, Karema C, Medin A, Bekele W, et al. Initial evidence of reduction of
malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and
treatment. Malar J. 2009; 8:14. Epub 2009/01/16. 1475-2875-8-14 [pii] doi: 10.1186/1475-2875-8-14
PMID: 19144183; PubMed Central PMCID: PMC2653503.
5. Mmbando BP, Vestergaard LS, Kitua AY, Lemnge MM, Theander TG, Lusingu JP. A progressive
declining in the burden of malaria in north-eastern Tanzania. Malar J. 2010; 9:216. Epub 2010/07/24.
1475-2875-9-216 [pii] doi: 10.1186/1475-2875-9-216 PMID: 20650014; PubMed Central PMCID:
PMC2920289.
6. O'MearaW. P. M JN, Steketee R., Greenwood B.,. Changes in the burden of malaria in sub-Saharan
Africa. Lancert Infect Dis. 2010;(10: ):545–55.
7. Bouyou-Akotet MK, Mawili-Mboumba DP, Kendjo E, Mabika-Mamfoumbi M, Ngoungou EB, Dzeing-
Ella A, et al. Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to
2008. Malar J. 2009; 8(1):300.
8. Kleinschmidt I, Schwabe C, Benavente L, Torrez M, Ridl FC, Segura JL, et al. Marked increase in child
survival after four years of intensive malaria control. The American journal of tropical medicine and
hygiene. 2009; 80(6):882–8. PMID: 19478243
9. Hetzel MW, Obrist B, Lengeler C, Msechu JJ, Nathan R, Dillip A, et al. Obstacles to prompt and effec-
tive malaria treatment lead to low community-coverage in two rural districts of Tanzania. BMC Public
Health. 2008; 8:317. Epub 2008/09/17. 1471-2458-8-317 [pii] doi: 10.1186/1471-2458-8-317 PMID:
18793448; PubMed Central PMCID: PMC2564938.
10. Tougher S, Ye Y, Amuasi JH, Kourgueni IA, Thomson R, Goodman C, et al. Effect of the Affordable
Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured arte-
misinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey
data. Lancet. 2012; 380(9857):1916–26. Epub 2012/11/06. S0140-6736(12)61732-2 [pii] doi: 10.1016/
S0140-6736(12)61732-2 PMID: 23122217.
11. WHO.World malaria report 2010. Geneva, Switzerland: World Health Organization, 2010a.
12. Malm KL, Segbaya S, Forson I, Gakpey KD, Sampong LB, Adjei EA, et al. Implementation of the Afford-
able Medicines for Malaria Facility (AMFm) in Ghana: processes, challenges and achievements. Jour-
nal of public health policy. 2013; 34(2):302–14. doi: 10.1057/jphp.2013.12 PMID: 23575513
13. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst
Rev. 2004; 2(2).
14. D'Acremont V, Lengeler C, Genton B. Reduction in the proportion of fevers associated with Plasmo-
dium falciparum parasitaemia in Africa: a systematic review. Malar J. 2010; 9:240. Epub 2010/08/24.
1475-2875-9-240 [pii] doi: 10.1186/1475-2875-9-240 PMID: 20727214; PubMed Central PMCID:
PMC2936918.
Antimalarial Use in Community Fever Management in Ghana
PLOSONE | DOI:10.1371/journal.pone.0142106 November 18, 2015 10 / 12
15. Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, et al. The decline in paediatric malaria
admissions on the coast of Kenya. Malaria journal. 2007; 6(1):151.
16. Baiden F, Malm K, Bart-Plange C, Hodgson A, Chandramohan D, Webster J, et al. Shifting from Pre-
sumptive to Test-Based Management of Malaria-Technical Basis and Implications for Malaria Control
in Ghana. Ghana Medical Journal. 2014; 48(2):112–22. PMID: 25667560
17. Gosling RD, Drakeley CJ, Mwita A, Chandramohan D. Presumptive treatment of fever cases as
malaria: help or hindrance for malaria control? Malaria journal. 2008; 7(1):132.
18. Osei-Kwakye K, Asante KP, Mahama E, Apanga S, Owusu R, Kwara E, et al. The benefits or otherwise
of managing malaria cases with or without laboratory diagnosis: the experience in a district hospital in
Ghana. PLoS One. 2013; 8(3):e58107. Epub 2013/03/19. doi: 10.1371/journal.pone.0058107 PONE-
D-12-26544 [pii]. PMID: 23505457; PubMed Central PMCID: PMC3591456.
19. WHO.World malaria report. Geneva: World Health Organisation, 2008.
20. Perkins MD, Bell DR. Working without a blindfold: the critical role of diagnostics in malaria control.
Malar J. 2008; 7 Suppl 1:S5. Epub 2009/02/20. 1475-2875-7-S1-S5 [pii] doi: 10.1186/1475-2875-7-S1-
S5 PMID: 19091039; PubMed Central PMCID: PMC2604880.
21. GHS. Ghana national antimalarial policy. Accra: Ghana Health Service, 2009.
22. Owusu-Agyei S, Nettey OE, Zandoh C, Sulemana A, Adda R, Amenga-Etego S, et al. Demographic
patterns and trends in Central Ghana: baseline indicators from the Kintampo Health and Demographic
Surveillance System. Glob Health Action. 2012; 5(0):1–11. Epub 2013/01/01. 19033 [pii]. PMID:
23273249.
23. Dery DB, Brown C, Asante KP, Adams M, Dosoo D, Amenga-Etego S, et al. Patterns and seasonality
of malaria transmission in the forest-savannah transitional zones of Ghana. Malar J. 2010; 9:314. Epub
2010/11/09. 1475-2875-9-314 [pii] doi: 10.1186/1475-2875-9-314 PMID: 21054895; PubMed Central
PMCID: PMC2989982.
24. Owusu-Agyei S, Asante KP, Adjuik M, Adjei G, Awini E, AdamsM, et al. Epidemiology of malaria in the
forest-savanna transitional zone of Ghana. Malar J. 2009; 8:220. Epub 2009/09/30. 1475-2875-8-220
[pii] doi: 10.1186/1475-2875-8-220 PMID: 19785766; PubMed Central PMCID: PMC2765449.
25. GSS. Ghana Demographic and Health Survey 2008. Accra: GSS, GHS, and ICF Macro, 2009.
26. Swysen C, Vekemans J, Bruls M, Oyakhirome S, Drakeley C, Kremsner P, et al. Development of stan-
dardized laboratory thods and quality processes for a phase III study of the RTS, S/AS01 candidate
malaria vaccine. Malar J. 2011; 10:223. Epub 2011/08/06. 1475-2875-10-223 [pii] doi: 10.1186/1475-
2875-10-223 PMID: 21816032; PubMed Central PMCID: PMC3220650.
27. GSS. Ghana Multiple Indicator Cluster Survey with Enhanced Malaria Module and Biomarker Accra:
Ghana Statistical Service, 2011.
28. Yusuf OB, Adeoye BW, Oladepo OO, Peters DH, Bishai D. Poverty and fever vulnerability in Nigeria: a
multilevel analysis. Malar J. 2010; 9:235. Epub 2010/08/20. 1475-2875-9-235 [pii] doi: 10.1186/1475-
2875-9-235 PMID: 20718997; PubMed Central PMCID: PMC2936404.
29. Novignon J, Nonvignon J. Socioeconomic status and the prevalence of fever in children under age five:
evidence from four sub-Saharan African countries. BMC Res Notes. 2012; 5:380. Epub 2012/07/31.
1756-0500-5-380 [pii] doi: 10.1186/1756-0500-5-380 PMID: 22840190; PubMed Central PMCID:
PMC3502087.
30. Owusu-Agyei S, Asante KP, Owusu R, Adjuik M, Amenga-Etego S, Dosoo DK, et al. An open label, ran-
domised trial of artesunate+ amodiaquine, artesunate+ chlorproguanil-dapsone and artemether-lume-
fantrine for the treatment of uncomplicated malaria. PLoS One. 2008; 3(6):e2530. doi: 10.1371/journal.
pone.0002530 PMID: 18575626
31. Asante KP, Owusu R, Dosoo D, Awini E, Adjei G, Amenga Etego S, et al. Adherence to artesunate-
amodiaquine therapy for uncomplicated malaria in rural Ghana: a randomised trial of supervised versus
unsupervised drug administration. Journal of tropical medicine. 2009; 2009.
32. Elmardi KA, Noor AM, Githinji S, Abdelgadir TM, Malik EM, Snow RW. Self-reported fever, treatment
actions and malaria infection prevalence in the northern states of Sudan. Malar J. 2011; 10:128. Epub
2011/05/18. 1475-2875-10-128 [pii] doi: 10.1186/1475-2875-10-128 PMID: 21575152; PubMed Central
PMCID: PMC3115918.
33. Asante KP, Zandoh C, Dery DB, Brown C, Adjei G, Antwi-Dadzie Y, et al. Malaria epidemiology in the
Ahafo area of Ghana. Malar J. 2011; 10:211. Epub 2011/08/02. 1475-2875-10-211 [pii] doi: 10.1186/
1475-2875-10-211 PMID: 21801344; PubMed Central PMCID: PMC3171375.
34. Abdelgader TM, Ibrahim AM, Elmardi KA, Githinji S, Zurovac D, Snow RW, et al. Progress towards
implementation of ACT malaria case-management in public health facilities in the Republic of Sudan: a
cluster-sample survey. BMC Public Health. 2012; 12:11. Epub 2012/01/10. 1471-2458-12-11 [pii] doi:
10.1186/1471-2458-12-11 PMID: 22221821; PubMed Central PMCID: PMC3268707.
Antimalarial Use in Community Fever Management in Ghana
PLOSONE | DOI:10.1371/journal.pone.0142106 November 18, 2015 11 / 12
35. Meyrowitsch DW, Pedersen EM, Alifrangis M, Scheike TH, Malecela MN, Magesa SM, et al. Is the cur-
rent decline in malaria burden in sub-Saharan Africa due to a decrease in vector population? Malar J.
2011; 10:188. Epub 2011/07/15. 1475-2875-10-188 [pii] doi: 10.1186/1475-2875-10-188 PMID:
21752273; PubMed Central PMCID: PMC3160426.
36. Crump JA, Morrissey AB, Nicholson WL, Massung RF, Stoddard RA, Galloway RL, et al. Etiology of
Severe Non-malaria Febrile Illness in Northern Tanzania: A Prospective Cohort Study. PLoS Negl Trop
Dis. 2013; 7(7):e2324. doi: 10.1371/journal.pntd.0002324 PMID: 23875053
37. Gething PW, Kirui VC, Alegana VA, Okiro EA, Noor AM, Snow RW. Estimating the Number of Paediat-
ric Fevers Associated with Malaria Infection Presenting to Africa's Public Health Sector in 2007. PLoS
Med. 2010; 7(7):e1000301. doi: 10.1371/journal.pmed.1000301 PMID: 20625548
38. Ansah EK, Narh-Bana S, Affran-Bonful H, Bart-Plange C, Cundill B, Gyapong M, et al. The impact of
providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a
cluster randomized trial. bmj. 2015; 350:h1019. doi: 10.1136/bmj.h1019 PMID: 25739769
39. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJC, et al. Changes in malaria
indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet. 2008; 372
(9649):1545–54. doi: 10.1016/S0140-6736(08)61654-2 PMC2607025. PMID: 18984187
40. Mazigo HD, MezaW, Ambrose EE, Kidenya BR, Kweka EJ. Confirmed malaria cases among children
under five with fever and history of fever in rural western Tanzania. BMC Res Notes. 2011; 4:359. Epub
2011/09/15. 1756-0500-4-359 [pii] doi: 10.1186/1756-0500-4-359 PMID: 21914203; PubMed Central
PMCID: PMC3180709.
41. WHO. Guidelines for the treatment of malaria. Second edition ed. Geneva: World Health Organisa-
tion; 2010 2010.
42. English M, Reyburn H, Goodman C, Snow RW. Abandoning presumptive antimalarial treatment for
febrile children aged less than five years—a case of running before we can walk? PLoSMed. 2009; 6
(1):e1000015. Epub 2009/01/09. 08-PLME-PMD-3329 [pii] doi: 10.1371/journal.pmed.1000015 PMID:
19127977; PubMed Central PMCID: PMC2613424.
43. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, et al. Monitoring fever treatment behav-
iour and equitable access to effective medicines in the context of initiatives to improve ACT access:
baseline results and implications for programming in six African countries. Malar J. 2011; 10:327. Epub
2011/11/02. 1475-2875-10-327 [pii] doi: 10.1186/1475-2875-10-327 PMID: 22039892; PubMed Central
PMCID: PMC3223147.
44. Asante KP, Abokyi L, Zandoh C, Owusu R, Awini E, Sulemana A, et al. Community perceptions of
malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combi-
nation therapy. BMC Public Health. 2010; 10:409. Epub 2010/07/14. 1471-2458-10-409 [pii] doi: 10.
1186/1471-2458-10-409 PMID: 20624306; PubMed Central PMCID: PMC2914078.
45. Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, et al. Pattern of drug utilization for
treatment of uncomplicated malaria in urban Ghana following national treatment policy change to arte-
misinin-combination therapy. Malar J. 2009; 8:2. Epub 2009/01/07. 1475-2875-8-2 [pii] doi: 10.1186/
1475-2875-8-2 PMID: 19123926; PubMed Central PMCID: PMC2647941.
46. Agnandji ST, Asante KP, Lyimo J, Vekemans J, Soulanoudjingar SS, Owusu R, et al. Evaluation of the
safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the
expanded program of immunization. J Infect Dis. 2010; 202(7):1076–87. Epub 2010/08/26. doi: 10.
1086/656190 PMID: 20735271.
47. Sabot O, Gordon M, Moonen B, Talisuna A, Amofah G. A path to an optimal future for the Affordable
Medicines Facility—malaria. Health policy and planning. 2011; 26(6):441–4. doi: 10.1093/heapol/
czr067 PMID: 21954212
Antimalarial Use in Community Fever Management in Ghana
PLOSONE | DOI:10.1371/journal.pone.0142106 November 18, 2015 12 / 12
